Globe Life Inc. (NYSE:GL) Shares Sold by Leavell Investment Management Inc.

Leavell Investment Management Inc. reduced its stake in shares of Globe Life Inc. (NYSE:GL) by 4.2% during the 4th quarter, HoldingsChannel reports. The firm owned 68,143 shares of the company’s stock after selling 3,013 shares during the quarter. Leavell Investment Management Inc.’s holdings in Globe Life were worth $7,599,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. Savant Capital LLC lifted its holdings in Globe Life by 0.3% in the fourth quarter. Savant Capital LLC now owns 56,045 shares of the company’s stock valued at $6,250,000 after acquiring an additional 149 shares during the last quarter. Canvas Wealth Advisors LLC lifted its holdings in Globe Life by 7.1% in the fourth quarter. Canvas Wealth Advisors LLC now owns 9,596 shares of the company’s stock valued at $1,070,000 after acquiring an additional 638 shares during the last quarter. Fairvoy Private Wealth LLC acquired a new position in Globe Life in the fourth quarter valued at approximately $1,367,000. Sumitomo Mitsui Trust Group Inc. lifted its holdings in Globe Life by 719.5% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 24,225 shares of the company’s stock valued at $2,702,000 after acquiring an additional 21,269 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. lifted its holdings in Globe Life by 39.5% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,988 shares of the company’s stock valued at $984,000 after acquiring an additional 2,547 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Stock Down 0.8 %

Globe Life stock opened at $121.31 on Wednesday. Globe Life Inc. has a twelve month low of $38.95 and a twelve month high of $132.00. The stock’s fifty day simple moving average is $113.67 and its 200-day simple moving average is $107.57. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $10.18 billion, a P/E ratio of 10.15 and a beta of 0.81.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, topping analysts’ consensus estimates of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. As a group, equities analysts expect that Globe Life Inc. will post 13.57 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Monday, January 6th were issued a $0.24 dividend. This represents a $0.96 annualized dividend and a yield of 0.79%. The ex-dividend date of this dividend was Monday, January 6th. Globe Life’s dividend payout ratio (DPR) is presently 8.03%.

Insider Activity at Globe Life

In related news, CEO Frank M. Svoboda sold 14,340 shares of the stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $108.80, for a total value of $1,560,192.00. Following the transaction, the chief executive officer now owns 16,396 shares of the company’s stock, valued at $1,783,884.80. This represents a 46.66 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Mark A. Blinn sold 3,000 shares of the stock in a transaction on Monday, January 6th. The shares were sold at an average price of $113.23, for a total value of $339,690.00. Following the completion of the transaction, the director now directly owns 5,122 shares in the company, valued at $579,964.06. This trade represents a 36.94 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 39,788 shares of company stock valued at $4,429,779 over the last quarter. 1.51% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms recently commented on GL. Jefferies Financial Group upped their price objective on Globe Life from $107.00 to $114.00 and gave the company a “hold” rating in a report on Tuesday, December 10th. Evercore ISI upgraded Globe Life from an “in-line” rating to an “outperform” rating and upped their price target for the stock from $132.00 to $143.00 in a research note on Wednesday, January 8th. Keefe, Bruyette & Woods upped their price target on Globe Life from $135.00 to $137.00 and gave the stock an “outperform” rating in a research note on Friday, January 10th. Morgan Stanley upped their price target on Globe Life from $123.00 to $125.00 and gave the stock an “equal weight” rating in a research note on Tuesday. Finally, Piper Sandler upped their price target on Globe Life from $118.00 to $130.00 and gave the stock an “overweight” rating in a research note on Friday, October 25th. Five research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $132.30.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.